Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Natalie Cunningham — Length: 04:37 Sustained Control of Pediatric Atopic Dermatitis with As-needed Topical JAK Inhibitor: Evidence from TRuE-AD3 Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Geeta Yadav — Length: 04:04 Insights from the TRuE-V Pivotal Trials: Durable Repigmentation in Vitiligo Following Topical JAK Inhibitor Use Watch Presentation
Infectious Disease HABP and VABP: Expert Discussion Dr. Zhanel & Dr. Rotstein — Length: 14:19 HABP and VABP Treatment: Update and Role of New IV Antimicrobials Watch Presentation
Dermatology European Academy of Dermatology and Venereology (EADV) 2024: Expert Interview Dr. Fiona Lovegrove — Length: 06:27 Exploring Treatment Options for Hidradenitis Suppurativa and Prurigo Nodularis: A Focus on JAK Inhibitors Watch Presentation
ophthalmology Anti-VEGF: eLearning Program Dr. Michael W. Stewart — Length: 20:02 Evolving Strategy for Extending Dosing Intervals: Lessons Learned from PULSAR and PHOTON Watch Presentation
Hematology European Hematology Association (EHA) 2024 Hybrid Congress: Expert Interview Dr. Christopher J. Patriquin — Length: 07:15 Broadening the PNH Treatment Landscape: Updates from APPOINT-PNH & APPLY-PNH Watch Presentation
Cardiology 10th European Stroke Organization Conference (ESOC) 2024 May 15-17, 2024 — Basel, Switzerland Stroke Therapy Targeted at Platelet Glycoprotein Still Considered Promising Despite Negative Trial Download 2 PowerPoint slides
Cardiology 10th European Stroke Organisation Conference (ESOC) 2024: Expert Interview Dr. Andrew Demchuk — Length: 08:46 ANNEXA-I Sub-Analyses: Balancing Unequal Risks in ICH Treatment Selection Watch Presentation
Cardiology 10th European Stroke Organisation Conference (ESOC) 2024 May 15-17, 2024 — Basel, Switzerland Balancing Relative Risk of Poor Functional Outcomes Guides Factor Xa Inhibitor Reversal Agent Selection Download 4 PowerPoint slides
psychiatry Difficult-to-treat Depression: Expert Discussion Dr. Sidney Kennedy & Dr. Jeffrey Habert — Length: 09:23 Navigating Difficult-to-treat Depression in Primary Care: A Shift Towards Earlier Use of Adjunct Medications Watch Presentation
psychiatry CANMAT Guidelines: Expert Review and Commentary Dr. Sidney Kennedy, Dr. Valérie Tourjman Primary Care: Updated CANMAT Guidelines for Navigating Poor Response in Major Depressive Disorder Download 2 PowerPoint slides
neurology hATTR-PN: Expert Interview Dr. Vera Bril — Length: 04:01 NEURO-TTRansform Trial: New Data in the Treatment of hATTR-PN Watch Presentation
